BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang N, Wang X, Li D, Sun Z. Validation of the PLASMIC score, a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis, in Chinese patients. Thrombosis Research 2018;172:9-13. [DOI: 10.1016/j.thromres.2018.10.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Reeves HM, Maitta RW. Comparison of absolute immature platelet count to the PLASMIC score at presentation in predicting ADAMTS13 deficiency in suspected thrombotic thrombocytopenic purpura. Thrombosis Research 2022. [DOI: 10.1016/j.thromres.2022.05.008] [Reference Citation Analysis]
2 Reddy MS, Newsom N, Sakurai S, Park SY, Reisch J, Sarode R. Performance of the PLASMIC score is improved with a positive score defined as ≥5 and with the inclusion of neurological symptoms. Br J Haematol 2022. [PMID: 35261027 DOI: 10.1111/bjh.18123] [Reference Citation Analysis]
3 Zhou L, Zhu Y, Jiang M, Su J, Liu X, Jiang Y, Mu H, Yin J, Yang L, Liu H, Pan W, Su M, Liu H. Pregnancy-associated thrombotic thrombocytopenic purpura complicated by Sjögren's syndrome and non-neutralising antibodies to ADAMTS13: a case report. BMC Pregnancy Childbirth 2021;21:804. [PMID: 34861845 DOI: 10.1186/s12884-021-04167-9] [Reference Citation Analysis]
4 Huang MJ, Deng JN, Gao LL, Zhou JF. Thrombotic thrombocytopenic purpura complicated with acute aortic dissection: A case report. Medicine (Baltimore) 2021;100:e27898. [PMID: 34797341 DOI: 10.1097/MD.0000000000027898] [Reference Citation Analysis]
5 Fage N, Orvain C, Henry N, Mellaza C, Beloncle F, Tuffigo M, Geneviève F, Coppo P, Augusto JF, Brilland B. Proteinuria Increases the PLASMIC and French Scores Performance to Predict Thrombotic Thrombocytopenic Purpura in Patients With Thrombotic Microangiopathy Syndrome. Kidney International Reports 2021. [DOI: 10.1016/j.ekir.2021.11.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Chen JK, Tang N, Wang X, Huang M, Zhang C. A Case of Parturient with Hereditary Thrombotic Thrombocytopenic Purpura: Case Report of a Novel Variant. Semin Thromb Hemost 2021. [PMID: 34388840 DOI: 10.1055/s-0041-1732466] [Reference Citation Analysis]
7 Gavriilaki E, Koravou E, Chatziconstantinou T, Kalpadaki C, Printza N, Ximeri M, Christoforidou A, Karavalakis G, Kaliou M, Kalaitzidou V, Tassi I, Tzellou M, Touloumenidou T, Papalexandri A, Papathanasiou M, Syrigou A, Kioumi A, Liga M, Kaiafa G, Spyridonidis A, Kapsali E, Kollios K, Mandala E, Vlachaki E, Tsirigotis P, Papadaki E, Lalayanni C, Sakellari I, Anagnostopoulos A. Real-world data of thrombotic microangiopathy management: The key role of ADAMTS13 activity and complement testing. Thrombosis Update 2021;3:100043. [DOI: 10.1016/j.tru.2021.100043] [Reference Citation Analysis]
8 Baysal M, Ümit E, Kırkızlar HO, Demir AM. Comparison of Clinical Scoring Systems in the Management of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia. Turk J Haematol 2021;38:64-8. [PMID: 33161686 DOI: 10.4274/tjh.galenos.2020.2020.0348] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Liu A, Dhaliwal N, Upreti H, Kasmani J, Dane K, Moliterno A, Braunstein E, Brodsky R, Chaturvedi S. Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals. Transfusion 2021;61:266-73. [PMID: 33179792 DOI: 10.1111/trf.16188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
10 Wynick C, Britto J, Sawler D, Parker A, Karkhaneh M, Goodyear MD, Sun HL. Validation of the PLASMIC score for predicting ADAMTS13 activity <10% in patients with suspected thrombotic thrombocytopenic purpura in Alberta, Canada. Thromb Res 2020;196:335-9. [PMID: 32977133 DOI: 10.1016/j.thromres.2020.09.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
11 Paydary K, Banwell E, Tong J, Chen Y, Cuker A. Diagnostic accuracy of the PLASMIC score in patients with suspected thrombotic thrombocytopenic purpura: A systematic review and meta-analysis. Transfusion 2020;60:2047-57. [PMID: 32757237 DOI: 10.1111/trf.15954] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
12 Yoon J, Lee S, Sun CH, Kim D, Kim I, Yoon SS, Oh D, Yun H, Koh Y. MED-TMA: A clinical decision support tool for differential diagnosis of TMA with enhanced accuracy using an ensemble method. Thromb Res 2020;193:154-9. [PMID: 32622194 DOI: 10.1016/j.thromres.2020.06.045] [Reference Citation Analysis]
13 Moosavi H, Ma Y, Miller MJ, Duncan A. Validation of PLASMIC score: an academic medical center case series (2012-present). Transfusion 2020;60:1536-43. [PMID: 32588918 DOI: 10.1111/trf.15916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
14 Gupta GK, Hendrickson JE, Tormey CA. Application of PLASMIC score in prediction of ADAMTS13 deficiency in a pediatric case of acquired thrombotic thrombocytopenic purpura. J Clin Apher 2020;35:140-1. [PMID: 31951292 DOI: 10.1002/jca.21767] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Zhao N, Zhou L, Hu X, Sun G, Chen C, Fan X, Zhou S, Tao X, Liu H, Zheng C. A modified PLASMIC score including the lactate dehydrogenase/the upper limit of normal ratio more accurately identifies Chinese thrombotic thrombocytopenic purpura patients than the original PLASMIC score. J Clin Apher 2020;35:79-85. [DOI: 10.1002/jca.21760] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]